← Back to Clinical Trials
Recruiting NCT07614945

NCT07614945 Effect of Reflexology on Pain and Sleep Disorders in Females With Fibromyalgia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07614945
Status Recruiting
Phase
Sponsor Cairo University
Condition Fibromyalgia
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2026-06-03
Primary Completion 2026-10-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Foot ReflexologyConventional Physical TherapyTranscutaneous Electrical Nerve Stimulation (TENS)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2026-06-03 with a primary completion date of 2026-10-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled trial aims to investigate the effect of foot reflexology on pain and sleep disorders in Egyptian female patients with fibromyalgia. Sixty female participants aged 18 to 65 years diagnosed with fibromyalgia will be randomly assigned into two equal groups. The control group will receive conventional physical therapy, including aerobic exercise, resistance training, and transcutaneous electrical nerve stimulation (TENS), while the experimental group will receive the same treatment in addition to foot reflexology. Interventions will be delivered twice weekly for six weeks. Pain, sleep quality, psychological distress, and functional activity will be evaluated at baseline and after treatment using validated Arabic assessment tools and pressure pain threshold measurements. The study aims to determine whether reflexology provides additional benefits when combined with conventional physical therapy in women with fibromyalgia.

Eligibility Criteria

Inclusion Criteria: * Egyptian female participants aged 18 to 65 years * Diagnosis of fibromyalgia according to American College of Rheumatology (ACR) criteria * Moderate pain intensity * Poor sleep quality * Ability and willingness to provide written informed consent Exclusion Criteria: * Comorbid conditions affecting pain or sleep, including rheumatoid arthritis and related disorders * Previous reflexology treatment within the previous 6 months * Any medical condition preventing participation in physical therapy or reflexology intervention * Refusal or inability to comply with study procedures and follow-up requirements

Contact & Investigator

Central Contact

Ghada M Mohamed El-Hady Ismaeil, BSc, PT

✉ 10722018823327@pg.cu.edu.eg

📞 +201005677669

Frequently Asked Questions

Who can join the NCT07614945 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Fibromyalgia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07614945 currently recruiting?

Yes, NCT07614945 is actively recruiting participants. Contact the research team at 10722018823327@pg.cu.edu.eg for enrollment information.

Where is the NCT07614945 trial being conducted?

This trial is being conducted at Al Mansurah, Egypt.

Who is sponsoring the NCT07614945 clinical trial?

NCT07614945 is sponsored by Cairo University. The trial plans to enroll 60 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology